NCT00272038View on ClinicalTrials.gov

Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Prostate Cancer
Interventions
DRUG

Tarceva

150mg QD

Trial Locations (1)

60068

Oncology Specialists, SC, Park Ridge

All Listed Sponsors
lead

Oncology Specialists, S.C.

OTHER

NCT00272038 - Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer | Biotech Hunter | Biotech Hunter